Results
Ipca Laboratories FY26 Net Profit Rises 74% to ₹1132.52 Crores
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting a 74% YoY rise in standalone net profit to ₹1132.52 crores.
Recommended a dividend of
